Opportunity Overview
The National Institutes of Health Office of Logistics and Acquisition Operations, supporting the National Heart, Lung, and Blood Institute, has issued Sources Sought notice 75N98026R00150 for CureSCi Long-Term Follow-Up (LTFU) Consortium: Coordinating Center Activities, Natural History Data Resource (NHDR), and Related Support. This is market research rather than a request for proposals and does not itself commit NIH to make an award.
The notice is managed from NIH in Bethesda/Rockville, Maryland. NIH is assessing qualified small-business capability under NAICS 541715 for a contemplated single contract with a potential ten-year period and an anticipated award around April 2028.
Deadline and Eligibility
Capability statements must be received by October 2, 2026 at 3:00 PM Eastern Standard Time (EST), using the time-zone wording published in the Sources Sought document. The notice is specifically for interested small businesses. Small-business status under NAICS 541715 must be certified by the Small Business Administration; organizations that are not small under this NAICS should not respond. Applicable HUBZone, SDVOSB, 8(a), VOSB, WOSB and small-disadvantaged classifications may also be identified.
Anticipated Scope
The contemplated work includes CureSCi consortium coordinating-center functions and continued operation of the Sickle Cell Disease Natural History Data Resource. Current solicitation-derived materials describe longitudinal clinical data collection, patient-reported outcomes, biospecimen collection support, data management and quality control, informatics, statistical analysis and reporting, metadata-catalog and document-library maintenance, website maintenance, meeting coordination, publications support, participant retention and engagement, educational materials, cohort expansion, site and subcontract management, and support for approved ancillary studies.
Qualifications and Capability Statement
Respondents must demonstrate multicenter clinical-study management experience and the personnel, systems, facilities, equipment, data-management, informatics, statistical, medical, scientific and administrative capabilities needed to perform the contemplated work. Capability statements must address each project requirement, employee count, relevant personnel qualifications, facilities and software, similar prior research projects and other information needed for NIH to evaluate capability.
Current solicitation-derived materials state a limit of 15 single-sided pages or 7.5 double-sided pages, using at least 12-point font. Submission is by email to Contracting Officer Elizabeth Bulger and Contract Specialist Jessica Williams, with Sources Sought notice number 75N98026R00150 in the subject line. The notice instructs respondents not to include proprietary, classified, confidential or sensitive information. A Sources Sought response will not substitute for any later solicitation response.
Funding, Cost Share, Forms and Amendments
No contract ceiling, guaranteed value or current award amount is published. This is federal procurement market research, not a grant, so no non-Federal match or grant cost share is stated. One source document, CureSCI_CC___NHDR_Sought_Notice_1.pdf, is identified. Current notice history shows one Sources Sought posting and no amendment. No separate application forms or FAQ package is identified in the materials reviewed by Atlas.
Atlas Analysis
Atlas Opportunity Score: 88/100. This is a substantial NIH clinical-research coordination, longitudinal data and informatics requirement with clear Maryland acquisition management and a long potential period, though it remains a market-research notice rather than a current award competition.
N9+ Fit Score: 0/100. The verified requirement centers on consortium coordination, clinical research operations, data resources, biospecimens, informatics and longitudinal follow-up. It does not establish remote physical-examination hardware or telehealth platform acquisition as a requirement, so Atlas will not force an N9+ fit.
QC Healthcare / Dr. Miltie Fit: 10/100 conditional. Dr. Miltie, LLC is NOT CLEARED / No Bid as a direct respondent on currently verified evidence. Atlas has not verified SBA-certified small-business eligibility under NAICS 541715, multicenter sickle-cell clinical-study management, NHDR-scale informatics/data-resource operations, biospecimen support, statistical infrastructure, qualifying scientific/medical staffing, research facilities/software, or comparable prior projects. None of those qualifications should be inferred or fabricated.
Required Next Action
Monitor SAM.gov for revisions and any resulting solicitation. A direct Dr. Miltie capability response should proceed only after every applicant-controlled small-business, clinical-research, scientific, staffing, facility, software, data-management, informatics, biospecimen and past-project requirement is independently verified.
Official source: SAM.gov — 75N98026R00150.
Last verified September 11, 2026.